Gallstone Disease Clinical Trial
Official title:
A Study to Pilot the Use of a Multimedia Application to Collect the Largest PROMs (Patient Reported Outcome Measures) Dataset in Adult Patients Undergoing Elective Laparoscopic Cholecystectomy for Symptomatic Gallstones and to Aid the Informed Consent Process
Collection of PROMs (Patient Reported Outcome Measures) data from patients before and after
an operation to remove their gallbladder for the treatment of symptomatic gallstones. This
PROMs data will provide information to clinicians and trusts about the health gain following
this type of surgery and the impact on patient's quality of life.
This information will be collected by the implementation of the patient Website
aboutmyop.org. This will not only allow patients to complete quality of life (PROMs)
questionnaires online, but will also allow them to access information on their condition and
necessary surgery, in addition to post-operative follow-up.
Patients referred with gallstone disease necessitating surgery (laparoscopic cholecystectomy)
will be invited to engage with our on-line interactive website. This will allow a two-way
exchange of information in a secure environment (N3 compliant) to inform the patient about
the risks, benefits, alternatives to surgery (cholecystectomy), and post- operative
expectations. Furthermore, it will inform clinicians about the patient's symptoms and
history, and record a pre-operative Patient Reported Outcome Measure (PROM). The patient's
understanding of the facts required for informed consent will be measured and a "Patient
Health & Understanding Report" generated for hospital clinicians. This will form part of the
electronic patient record, and will be a medico-legal document.
As with current practice patients will still attend their initial outpatient clinic
appointment where they will meet a surgeon who will determine the appropriateness of surgery.
Informed consent for surgery (cholecystectomy) will be obtained at this initial consultation
facilitated by the information obtained from the "Patient Health & Understanding Report". The
patient will then continue to interact with the on-line platform before and after their
operation to ensure they are well informed and to monitor their post-operative progress.
7 days after surgery the patient will be prompted to interact with the website to answer
questions about their progress and recovery. This will replace the existing telephone
follow-up interaction. Any problems identified will trigger a protocol driven interaction
between the hospital and the patient.
At 1, 3 and 6 months after surgery a post-operative PROMs questionnaire will be answered by
the patient allowing comparison of pre- and post-operative PROMs. This study will lead to the
largest PROMs assessment of the effectiveness of laparoscopic cholecystectomy, will study the
feasibility of our Website as a multimedia application in assisting with the process of
informed consent, and will determine whether telephone follow-up can be safely replaced by a
protocol driven online system.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05618626 -
Prevention of NAFLD and CVD Through Lifestyle Intervention
|
N/A | |
Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
Completed |
NCT02351492 -
Radiological Investigation of Bile Duct Obstruction
|
N/A | |
Recruiting |
NCT06405906 -
A Randomized Controlled Trial Comparing Fat-free Versus Balanced (WHO) Diet in Gallstone Disease
|
N/A | |
Completed |
NCT06258824 -
MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers
|
||
Completed |
NCT01873638 -
Comparing Minilaparotomy and Laparoscopic Cholecystectomy as a Day Surgery Procedure
|
N/A | |
Recruiting |
NCT06239233 -
Gallbladder Infundibulum as a Guide for Ductal Identification.
|
||
Recruiting |
NCT05689255 -
Gut Microbiome and Metabolome in Patients With Gallstone Disease After Surgical and Endoscopic Interventions
|
||
Not yet recruiting |
NCT02300480 -
Effects of Calot's Triangle Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Double-blind, Controlled, Clinical Trial
|
Phase 4 | |
Recruiting |
NCT05928286 -
Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice
|
||
Recruiting |
NCT06192719 -
EULAT Eradicate GBC
|
||
Completed |
NCT01583348 -
Technical Feasibility of Routine Intraoperative Cholangiography During Elective Rigid-hybrid Transvaginal Natural Orifice Transluminal Endoscopic Cholecystectomy
|
N/A |